Predicting concentrations in children presenting with acetaminophen overdose

被引:48
作者
Anderson, BJ
Holford, NHG
Armishaw, JC
Aicken, R
机构
[1] Auckland Childrens Hosp, Dept PICU, Auckland, New Zealand
[2] Auckland Childrens Hosp, Dept Emergency Med, Auckland, New Zealand
[3] Univ Auckland, Sch Med, Dept Pharmacol & Clin Pharmacol, Auckland 1, New Zealand
关键词
D O I
10.1016/S0022-3476(99)70122-8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: To predict serum concentrations to evaluate and improve guidelines for the treatment of children (1 to 5 years) with accidental ingestion of acetaminophen elixir. Methods: Acetaminophen concentrations for 1000 children were simulated with pharmacokinetic parameters and their expected variability. The distribution of concentrations arising from a 300 mg/kg dose at different age groups was predicted. These predictions were validated by comparison with concentrations obtained at. 4 hours from 121 children with accidental ingestion of acetaminophen elixir. Results: No child who presented with overdose had a concentration in the probable risk area of the Rumack-Matthew toxicity nomogram. Enteral charcoal administered 98 minutes (SD 44) after ingestion had no effect on serum concentrations. The simulation predicted that an acetaminophen dose of 300 mg/kg would result in concentrations of 32 to 208 mg/L (95% CI) at 4 hours after ingestion. The maximum concentration occurred before 2 hours in 95% of simulated children. Conclusion: Children (1 to 5 years) with reported ingestion of >250 mg/kg acetaminophen elixir should have serum concentrations measured at 2 hours after ingestion rather than at the 4-hour time point recommended in adults. This can be expected to speed discharge and reduce anxiety The use of enteral charcoal is unlikely to enhance acetaminophen elimination, unless it is given within an hour of acetaminophen ingestion.
引用
收藏
页码:290 / 295
页数:6
相关论文
共 26 条
  • [11] A size standard for pharmacokinetics
    Holford, NHG
    [J]. CLINICAL PHARMACOKINETICS, 1996, 30 (05) : 329 - 332
  • [12] PHARMACOKINETICS AND PHARMACODYNAMICS OF IBUPROFEN ISOMERS AND ACETAMINOPHEN IN FEBRILE CHILDREN
    KELLEY, MT
    WALSON, PD
    EDGE, JH
    COX, S
    MORTENSEN, ME
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (02) : 181 - 189
  • [13] LEVY G, 1976, PEDIATRICS, V58, P432
  • [14] PARACETAMOL POISONING IN CHILDREN
    MEREDITH, TJ
    NEWMAN, B
    GOULDING, R
    [J]. BRITISH MEDICAL JOURNAL, 1978, 2 (6135) : 478 - 479
  • [15] *PHARS CORP, 1997, PHARS TRIAL DES VERS
  • [16] PRESCOTT LF, 1971, LANCET, V1, P519
  • [17] PARACETAMOL OVERDOSAGE - PHARMACOLOGICAL CONSIDERATIONS AND CLINICAL MANAGEMENT
    PRESCOTT, LF
    [J]. DRUGS, 1983, 25 (03) : 290 - 314
  • [18] GASTROINTESTINAL ABSORPTION OF DRUGS
    PRESCOTT, LF
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 1974, 58 (05) : 907 - 916
  • [19] SCALING OF BLOOD PARAMETERS IN MAMMALS
    PROTHERO, JW
    [J]. COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-PHYSIOLOGY, 1980, 67 (04): : 649 - 657
  • [20] COMPARATIVE ANTIDOTAL EFFICACY OF ACTIVATED-CHARCOAL TABLETS, CAPSULES AND SUSPENSION IN HEALTHY-VOLUNTEERS
    REMMERT, HP
    OLLING, M
    SLOB, W
    VANDERGIESEN, WF
    VANDIJK, A
    RAUWS, AG
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (05) : 501 - 505